Basic Information
ID: ALA1137548
Journal: Bioorg Med Chem Lett
Title: Synthesis and evaluation of naphthyridine compounds as antimalarial agents.
Authors: Zhu S, Zhang Q, Gudise C, Meng L, Wei L, Smith E, Kong Y.
Abstract: Primaquine is the drug of choice for the radical cure of Plasmodium vivax malaria, but possesses serious side effects. In this study novel primaquine analogues were designed and synthesized. Lower toxicity was achieved by reducing or eliminating the tendency of forming chemically reactive and toxic intermediates and metabolites. In vitro and in vivo studies found that synthesized compounds were less toxic than the parent compound primaquine, while preserving the desired antimalarial activity. Some of these compounds possess a therapeutic index over 10 times superior to that of the commonly used antimalarial drug chloroquine. These compounds, as well as the underlying design rationale, may find usefulness in the discovery and development of new antimalarial drugs.
CiteXplore: 17900897
DOI: 10.1016/j.bmcl.2007.09.044
Patent ID: ┄
Associated Items: Associated Bioactivities Associated Assays Associated Compounds Associated Targets